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OBJECTIVE — To evaluate the prevalence of lower-limb complications in a multiracial co-
hort of patients with diabetes receiving dialysis.
RESEARCH DESIGN AND METHODS — This work was a cross-sectional study of
lower-limb complications in dialysis-treated patients with diabetes in the U.K. and U.S.
RESULTS — We studied 466 patients (139 U.K.; 327 U.S.). The prevalence of lower-limb
complications was high (foot ulcers 12%, neuropathy 79%, peripheral arterial disease 57%,
history of foot ulceration 34%, and prior amputation 18%), with no signiﬁcant ethnic variation,
except that foot ulcers were more common in whites than in patients of African descent (P 
0.013). Ninety-ﬁve percent of patients were at high risk of lower-limb complications. Prior
amputation was related to foot ulcer history, peripheral arterial disease, and hemodialysis mo-
dality in multivariable analysis. Prevalent ulceration showed independent associations with foot
ulcer history and peripheral arterial disease, but not with ethnicity.
CONCLUSIONS — Allpatientswithdiabetesreceivingdialysisareathighriskoflower-limb
complications independent of ethnic background.
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A
mong individuals with diabetes,
signiﬁcant ethnic differences in
lower-limb complications have
been identiﬁed in the U.K. (1) and the
U.S. (2). Previous studies linking renal
impairment or end-stage renal disease to
lower-limb complications have been ret-
rospective and have not considered eth-
nicity (3,4). We aimed to establish the
prevalence of lower-limb complications
by ethnic group in dialysis-treated dia-
betic patients.
RESEARCH DESIGN AND
METHODS— This was a prospec-
tively designed cross-sectional study in-
cluding patients with diabetes receiving
dialysistherapyfromcentersinManches-
ter (U.K.) and Texas (U.S.). During rou-
tine clinic appointments, patients were
interviewedandhadadetailedfootexam-
ination including neurological (5,6) and
peripheral arterial disease (PAD) assess-
ment.Datawerecollectedondiabetesand
dialysis status, foot conditions, foot care,
and footwear. Peripheral neuropathy was
deﬁned as vibration perception threshold
25 V (Neurothesiometer; Horwell Sci-
entiﬁc Laboratory Supplies, Nottingham,
U.K.) and/or a modiﬁed neuropathy dis-
abilityscore3(5,6).PADwasdeﬁnedas
follows: ankle/brachial pressure index
(ABPI) 0.9 (7), a history of peripheral
artery revascularization or angiography
conﬁrming PAD, noncompressible arter-
ies (ABPI 1.4 with monophasic or bi-
phasic waveforms) (8), or the absence of
two or more foot pulses on palpation (9).
The International Working Group on
the Diabetic Foot (IWGDF) risk classiﬁ-
cation was used to assign patients into
fourlevelsofincreasingriskoflower-limb
complications (9): no recognizable risk
factor (risk category 0); neuropathy and
no other risk factors (risk category 1);
PAD with or without neuropathy (risk
category2);orprevalentfootulceration,a
history of foot ulcer, or prior amputation
(risk category 3). Patients in risk catego-
ries 1, 2, or 3 were considered to be at
high risk of lower-limb complications.
Ethnicity was based on patient self-
report. The study received prior approval
from the relevant ethics committee and
review boards.
Pearson’s 
2 and Fisher’s exact tests
were used for between-group compari-
sonsofcategoricaldata.ANOVAwasused
to assess the inﬂuence of ethnic group on
lower-limb complications. Proportions of
patients with lower-limb complications
are presented with 95% CI estimated by
the modiﬁed Wald method. Univariate
analysis was performed to identify factors
associated with prevalent foot ulceration
or prior amputation, and variables with
signiﬁcant associations were included in
multivariate logistic regression. P  0.05
was considered statistically signiﬁcant.
Analyses were performed using SPSS ver-
sion 15.0 (SPSS, Chicago, IL).
RESULTS— We studied 466 patients
(139 U.K., 327 U.S.). Eighty-eight per-
cent were receiving hemodialysis; the re-
mainder received peritoneal dialysis.
Recruitmentcenter(U.K.orU.S.)wasnot
associated with prevalent foot ulcer or
prior amputation in univariate analysis.
We observed a high prevalence of PAD
and peripheral neuropathy and a moder-
ately high prevalence of past foot ulcer-
ationandamputationthatdidnotvaryby
ethnicity (Table 1). The only foot compli-
cationthatvariedbyethnicitywascurrent
foot ulceration, which affected approxi-
mately one in eight patients, with whites
having a higher prevalence than patients
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0.013) but not signiﬁcantly higher than
Asians or Hispanics. Based on IWGDF
risk categories, 95% of all patients were
considered to be high risk.
Prevalentfootulcerationshoweduni-
variate associations with PAD (OR [95%
CI]:4.5[2.1–9.4],P0.0001),footulcer
history (3.1 [1.7–5.4], P  0.0001), reti-
nopathy (4.0 [1.9–8.3], P  0.0001),
white ethnicity (2.1 [1.2–3.7], P 
0.008), and failure to wear bespoke foot-
wear(2.1[1.2–3.6],P0.010).Prevalent
foot ulceration remained independently as-
sociated with PAD (4.1 [1.9–8.6], P 
0.0001) and foot ulcer history (2.8 [1.6–
5.1], P  0.001) in multivariate analysis.
Prior amputation showed univariate
associations with foot ulcer history (46
[19–110], P  0.0001), PAD (3.8 [2.1–
6.8],P0.0001),failuretowearbespoke
footwear(3.8[2.3–6.2],P0.0001),he-
modialysis modality (2.9 [1.1–8.3], P 
0.023), peripheral neuropathy (2.3 [1.1–
4.7],P0.016), male sex (1.7 [1.1–2.8],
P  0.019), and retinopathy (1.6 [1.0–
2.7], P  0.043). Prior amputation was
independently associated with foot ulcer
history (42 [17–100], P  0.0001), PAD
(4.1 [2.9–8.4], P  0.0001), and hemo-
dialysismodality(17[2–132],P0.008)
in multivariate analysis.
CONCLUSIONS — We report a high
prevalence of lower-limb complications
in a large ethnically diverse cohort of di-
abeticpatientsondialysis,withupto95%
of them having at least one recognizable
risk factor for foot ulceration. Contrary to
previous reports of ethnic variations of
foot complications in diabetes (1,2), we
observed no ethnic variation in prevalent
foot complications in our dialysis-treated
cohort, except for prevalent foot ulcer-
ation. This may be due to these patients
having a heavy burden of systemic end-
stage microvascular and macrovascular
disease, such that ethnic differences be-
come relatively insigniﬁcant.
Diabeticpatientswithend-stagerenal
disease are likely to have falsely elevated
ABPI levels (10,11), and ABPI measure-
ments are less able to detect occlusion in
arterial segments distal to the ankle,
which might be detected by palpation of
distal pedal pulses. Therefore, we used a
combination of criteria to deﬁne subjects
with PAD.
Our data conﬁrm and extend previ-
ous reports on diabetic foot disease in the
end-stage renal disease population
(12,13). The strengths of our study in-
clude the following: the large multiethnic
sample providing reliable prevalence
data, the inclusion of U.K. and U.S. cen-
ters, and a comprehensive assessment of
foot pathology. Our study is limited by
the small number of patients receiving
peritoneal dialysis and suboptimal infor-
mation on preventative and therapeutic
care.
Althoughthiswasnotanintervention
study, we believe that our ﬁndings have
immediate implications for foot care de-
livery. Because we found that 95% of di-
alysis-treated diabetic patients are at high
risk for foot problems, we suggest that all
such patients should be considered to be
high risk. Dialysis-treated patients may
fail to attend for appropriate foot care,
since they are too concerned with the de-
mands of dialysis (14); therefore, sched-
uling foot evaluation, education, and
interventions during or immediately after
dialysis may be a key component of effec-
tive prevention (15).
In summary, diabetic patients treated
with dialysis have a high prevalence of
foot ulceration, amputation, and the
“high-risk foot” that is similar across all
ethnic groups. Comprehensive and mul-
tidisciplinary diabetic foot care should be
offered to all patients and be integrated
within dialysis services.
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Table 1—Prevalence of foot ulcers, amputations, and risk factors for developing lower-limb complications by ethnic groups
White Hispanic African Asian Total
P (ANOVA for
ethnicity)
n 196 165 70 35 466
Age (years) 61  14 61  12 59  13 57  12 60  13 0.363
Sex (% male) 55 52 53 57 53 0.896
Diabetes (% type 1) 23 4 6 11 13 0.001
Time since diagnosis of diabetes (years) 21  11 18  10 21  10 17  92 0  10 0.012
Glycated hemoglobin (%) 7.4  1.7 6.9  1.4 7.2  1.8 7.6  1.2 7.2  1.6 0.005
Current foot ulcer* (%) 16 (12–22) 10 (6–15) 4 (1–12) 11 (4–27) 12 (9–15) 0.041
Past foot ulcer* (%) 36 (30–43) 34 (27–41) 30 (20–41) 20 (10–36) 33 (29–38) 0.277
Past or present foot ulcer* (%) 42 (35–49) 39 (32–46) 34 (24–46) 26 (14–42) 38 (34–43) 0.276
Amputation* (%) 15 (11–21) 20 (15–27) 21 (13–32) 9 (2–23) 18 (14–21) 0.286
PAD* (%) 54 (47–61) 58 (50–65) 63 (51–73) 54 (38–69) 57 (52–61) 0.672
Peripheral neuropathy* (%) 82 (76–87) 76 (69–82) 79 (68–87) 89 (73–96) 80 (76–83) 0.313
IWGDF risk category
0: No risk factors (%) 5 (3–9) 5 (2–9) 3 (0.1–10) 0 (0–12) 4.5 (3–7) 0.208†
1: DPN only (%) 9 (6–13) 2 (0.4–5) 6 (2–14) 29 (16–45) 7 (5–10)
2: PAD  neuropathy (%) 44 (37–51) 55 (47–62) 57 (45–68) 46 (30–62) 50 (45–54)
3: Present or past ulcer or amputation (%) 43 (36–50) 39 (32–46) 34 (24–46) 26 (14–42) 39 (34–43)
Data are n, means  SD, or % (95% CI). White includes all Europeans and similar white origins (U.K.) and non-Hispanic whites (U.S.). The only Native American
(n  1) was included in the white group. Hispanic includes Mexican Americans and similar Hispanic origins (U.S.). African includes people of African descent in
theU.K.(African-Caribbeans)andU.S.(AfricanAmericans).AsianincludesIndo-AsiansorsimilarAsianorigin(U.K.only).*95%CIsarecalculatedbythemodiﬁed
Wald method. †Multiple comparison test of variance (Bonferroni correction) conﬁrmed there was no difference between the ethnic groups.
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